What is Naloxone?
Naloxone is a medicine which can temporarily reverse the effects of an overdose caused by opiates and opioids such as heroin, methadone or morphine.
The main life-threatening effect of opiates is to slow down and stop breathing. Naloxone blocks this effect and reverses the breathing difficulties.
In June 2016 Public Health England released guidance on widening the availability of naloxone which has been updated in August 2017
The resulting regulations mean that anyone involved in delivering drug treatment services can now carry naloxone and make it available to others without a prescription. For example, a worker in a drug treatment service could supply naloxone to a family member or friend of a person using heroin, or to a manager of a hostel whose clients include people who use heroin.
The PHE guidelines include information on:
- What the new regulations mean
- Who can supply naloxone
- Products that drug services can supply
- Responsibility for deciding who can actually supply naloxone locally
- People who can be supplied naloxone
- Patient Group Directions and Patient Specific Directions
- Naloxone’s status as a prescription only medicine
- Using naloxone to save a person’s life without their permission
- Clinical governance in drug treatment services
- Guidance for hostels/homeless shelters/housing associations, etc
- Cost-effectiveness of widening availability
- Risks associated with widening availability
This video from the EMCDDA explains the reasons why increased naloxone availability is important and how the drug is being used throughout Europe.
How to administer Naloxone
See also the website of the Naloxone Acton Group for more information on this life saving drug.
Guidance: Widening the availability of naloxone, 2017
Naloxone is the emergency antidote for overdoses caused by heroin and other opiates/opioids (such as methadone and morphine) | DoH et al, UK
Take-home naloxone for opioid overdose in people who use drugs (PDF), 2017
Advice for local authorities and local partners on widening the availability of naloxone to reduce overdose deaths from heroin and other opiate drugs | PHE, UK
Updated August 2017